Co-Diagnostics Signs MOU for Middle East Expansion of Point-of-Care Platform
MT Newswires Live
Sep 16
Co-Diagnostics (CODX) said Tuesday it signed a memorandum of understanding with an undisclosed regional manufacturing and distribution company in Saudi Arabia to explore a joint venture with a license to develop, manufacture and sell its Co-Dx technology in the Middle East and North Africa,
The agreement includes the company's upcoming Co-Dx PCR point-of-care platform.
The Saudi partner will contribute local operational support, infrastructure, personnel and regulatory expertise, and the joint venture may benefit from applicable government incentives, Co-Diagnostics said.
Price: 0.36, Change: +0.01, Percent Change: +2.55
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.